Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

7 treatments under study, led by Mild Procedure

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed with results

Key Signals

3 with results67% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Completed2
Unknown1
Withdrawn1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT03610737Not ApplicableUnknownPrimary

The MOTION Study - Treatment of LSS With the MILD Procedure

NCT03863067Not ApplicableCompletedPrimary

Clinical Effectiveness, Security And Radiological Changes In Epiduroscopy For Lumbar Stenosis

NCT03048955Not ApplicableWithdrawnPrimary

Assessing Superion Clinical Endpoints vs. Decompression

NCT02093520Not ApplicableCompletedPrimary

The MiDAS ENCORE Study

NCT01995461Not ApplicableTerminatedPrimary

Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis

Showing all 5 trials

Research Network

Common Treatments

  • Mild Procedure2
  • Epidural Steroid Injection1
  • Bilateral Transforaminal Epidural Steroid Injections1
  • Conventional Medical Management Cmm1
  • Direct Decompression Surgery1

Active Sponsors

  • Vertos Medical, Inc.2
  • VertiFlex, Incorporated1
  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1
  • Marshfield Clinic Research Foundation1

Top Investigators

Activity Timeline